Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Ariad halts patient enrolment for cancer drug studies

Concerns raised after patients taking Iclusig experience blood clots and cardiovascular events

- PMLiVE

Gilead halts leukaemia study on positive results

Idelalisib provides significant benefit in chronic lymphocytic leukaemia

- PMLiVE

New faces at Red Door

Suzanne Walsh, Georgina Grant and Abigail Thomson appointed senior account managers at comms firm

ABPI London offices

ABPI announces review of Code

Trade body to update standards for pharma industry in UK

- PMLiVE

Incisive Health launches to focus on comms in health policy

Founded by trio behind MHP Health Mandate

- PMLiVE

Lundbeck and Otsuka take Alzheimer’s drug into phase III

Lu AE58054 affects levels of serotonin in the brain

- PMLiVE

EUSA Pharma founder to chair Glide Pharma

Bryan Morton replaces Mark Kirby

The problem with the new

Avoid being labelled either ‘risk taker’ or ‘Luddite’ by being a ‘considered adopter’

- PMLiVE

Janssen buys hepatitis C candidate from GSK

J&J subsidiary acquires rights to NS5A inhibitor

- PMLiVE

Bayer gets US nod for first-in-class Adempas

FDA clears drug for use in pulmonary artery hypertension

- PMLiVE

Lilly enters cancer collaboration in China

Signs deal with Chi-Med to develop and commercialise fruquintinib

- PMLiVE

Boehringer shuts Ben Venue unit

About 1,100 jobs expected to be lost at troubled manufacturing site

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links